SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005444
Filing Date
2020-05-06
Accepted
2020-05-06 17:07:03
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20200331x10q.htm 10-Q 1459460
2 EX-31.1 ampe-20200331ex311142247.htm EX-31.1 18895
3 EX-31.2 ampe-20200331ex312d109c4.htm EX-31.2 18757
4 EX-32.1 ampe-20200331ex32184addd.htm EX-32.1 10093
5 GRAPHIC ampe20200331x10q001.jpg GRAPHIC 4975
  Complete submission text file 0001558370-20-005444.txt   6448532

Data Files

Seq Description Document Type Size
6 EX-101.INS ampe-20200331.xml EX-101.INS 1561589
7 EX-101.SCH ampe-20200331.xsd EX-101.SCH 49778
8 EX-101.CAL ampe-20200331_cal.xml EX-101.CAL 44892
9 EX-101.DEF ampe-20200331_def.xml EX-101.DEF 157237
10 EX-101.LAB ampe-20200331_lab.xml EX-101.LAB 349022
11 EX-101.PRE ampe-20200331_pre.xml EX-101.PRE 309808
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 20853519
SIC: 2834 Pharmaceutical Preparations